The effect of pre-eclampsia on coagulation and fibrinolytic activation in the neonate.
Higgins
J R
JR
Rotunda Hospital, Dublin, Ireland. j.higgins@obsgyn-mercy.unimelb.edu.au
Bonnar
J
J
Norris
L A
LA
Darling
M R
MR
Walshe
J J
JJ
D000328:Adult; D000704:Analysis of Variance; D000933:Antifibrinolytic Agents / Q000097:blood; D000990:Antithrombin III / Q000378:metabolism; D001724:Birth Weight; D001777:Blood Coagulation / Q000502:physiology*; D005260:Female; D005312:Fetal Blood / Q000737:chemistry; D005338:Fibrin Fibrinogen Degradation Products; D005342:Fibrinolysis / Q000502:physiology*; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D010447:Peptide Hydrolases / Q000378:metabolism; D011225:Pre-Eclampsia / Q000097:blood / Q000503:physiopathology; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000378:metabolism
D000933:Antifibrinolytic Agents; D005338:Fibrin Fibrinogen Degradation Products; C046193:antithrombin III-protease complex; C036309:fibrin fragment D; D000990:Antithrombin III; D010447:Peptide Hydrolases